The coronavirus pandemic has propelled Australia's health spending to $115 billion this financial year.
Tuesday's federal budget reveals health funding will be $467 billion over the next four years.
That spending takes in aged care, mental health, medical research and listings on the Pharmaceutical Benefits Scheme.
Ventolin to treat asthma will be added to the PBS from August, followed by a leukaemia treatment in September and a Parkinson's disease treatment in October.
The funding also covers the ongoing coronavirus response which includes mental health support and the COVID-19 vaccine and treatment strategy.
Australians struggling with their mental health because of the coronavirus pandemic will be able to get an extra 10 psychological therapy sessions, taking the total to 20.
More than $20 million will go towards coronavirus related communications, $6.8 million for the central patient triage hotline and $15.4 million for the national incident room.
The government is putting $1.7 billion over two years towards the University of Oxford/AstraZeneca and University of Queensland/CSL Limited vaccines.
Dependents allowed under private health insurance policies can now be 31 years, up from 24.
The age limit for dependants with a disability has been removed.
The health measures also include close to $2 million over four years to increase access to kava in Australia.
The federal government will make $1.7 million over four years by regulating medicinal cannabis research, cultivation and manufacture.
